Recall Register

Meridian Bioscience Inc: FDA recalls

Newest recall start date in this list: . Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

FDA enforcement events from 2014 to 2025; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Meridian Bioscience Inc as the recalling firm in 11 events. The events have 15 product records. The recalls started from 2014 to 2025. All the events are device recalls. By FDA enforcement events, Meridian Bioscience Inc is number 324 of 1,629 firms that have a page. Events that Meridian Bioscience Inc started: none in 2024 and 2 in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 100.0% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

11 events, newest first.

FDA enforcement events of Meridian Bioscience Inc
InitiatedProduct (first record)TypeClassRecordsStatus
5 Dec 2025Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300DeviceClass II1Ongoing
7 Oct 2025Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test AssayDeviceClass II2Ongoing
19 Oct 2023Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of stool specimens containing intestinal parasites Catalog Number: 900312DeviceClass II3Ongoing
15 Dec 2022Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700DeviceClass II1Ongoing
22 Jun 2022Revogene, Catalog no. 610210. IVD test instrumentDeviceClass II1Ongoing
15 Feb 2022Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories. Meridian branded Revogene: Catalog Number 610210 GenePOC branded Revogene: Catalog Number 130840DeviceClass II1Ongoing
8 Apr 2021Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19DeviceClass II2Terminated
8 Feb 2021The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.DeviceClass II1Terminated
17 Dec 2018PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER Cryptococcal Antigen enzyme immunoassay (EIA) is a screening or a semi-quantitative test system for the detection of capsular polysaccharide antigens of Cryptococcus neoformans in serum and cerebrosoinal fluid (CSF).DeviceClass II1Terminated
8 Nov 2016PREMIER EHEC and PREMIER EHEC Bulk.DeviceClass II1Terminated
22 Apr 2014illumipro-10 Incubator/Reader, Meridian Bioscience, Inc. The illumipro-10 incubator/reader is designed to be used with illumigene Molecular Assays. The device incubates illumigene Test Devices and reads endpoint reactions.DeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Meridian Bioscience Inc: events for each product type
TypeEvents
Device11
Meridian Bioscience Inc: events in each class
ClassEvents
Class II11
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
6

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Meridian Bioscience Inc, by the year that the recall started. The largest year is 2022, with 3 events.

Official channels

Cite this page

Recall Register. Meridian Bioscience Inc: FDA recalls. https://recallregister.com/firm/meridian-bioscience-inc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
OH

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Meridian Bioscience Inc have?
Class II: 11 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Meridian Bioscience Inc?
FDA event 98038, which the firm started on 5 Dec 2025. The first product in the record is: Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
How many FDA recalls of Meridian Bioscience Inc have the status Ongoing?
6 events have the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.